Zeposia FDA Approval History
FDA Approved: Yes (First approved March 25, 2020)
Brand name: Zeposia
Generic name: ozanimod
Dosage form: Capsules
Company: Bristol-Myers Squibb Company
Treatment for: Multiple Sclerosis
Zeposia (ozanimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).
Development Timeline for Zeposia
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
